title: Determination of free cisplatin in medium by differential pulse polarography after ultrasound and cisplatin treatment of a cancer cell culture.
abstract: The in vitro study was carried out for detection of the cisplatin in free form and in culture medium, depending on various conditions of sonodynamic human ovarian cancer cells A2780 treatment by differential pulse polarography (DPP). For sonodynamic treatment, we used cisplatin alone and combined cisplatin/ultrasound treatments. The ultrasound exposure intensity of 1.0 and 2.0 W x cm(-2) in far field for incubation periods 1, 24 and 48 h was used. The parameters of DPP measurements were--1 s drop time, 5 mV x s(-1) voltage scan rate, 50 mV modulation amplitude and negative scanning direction; platinum wire served as counter electrode and Ag/AgCl/3 M KCl as reference electrode. The results showed the dependence of free platinum quantities in culture medium on incubation time and treatment protocol. We found difference in concentration of free cisplatin between conventional application of cisplatin and sonodynamic treatment. The sonodynamic combined treatment of cisplatin and ultrasound field showed a higher cisplatin content in the culture medium than cisplatin treatment alone; a difference of 20% was observed for incubation time 48 h. The results also showed the influence of a time sequence of ultrasound and cytostatics in the sonodynamic treatment. The highest amount of free cisplatin in the solution was found for primary application of cisplatin and the subsequent ultrasound exposure. The quantity of free cisplatin increased with time, namely for time intervals 1-24 h. There was no difference between the DPP signal of cisplatin in reaction mixture containing cells in small quantities and micro-filtered mixture without cells. Thus, the DPP method is suitable for the detection and quantification of free cisplatin in the culture medium of cell suspension. Ultrasound field can be important factor during cytostatic therapy.
authors.affiliation: Department of Biophysics, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic. vbernard@med.muni.cz
authors.forename: Vladan
authors.initials: V
authors.lastname: Bernard
authors.forename: Lukás
authors.initials: L
authors.lastname: Fojt
authors.forename: Jirina
authors.initials: J
authors.lastname: Skorpíková
authors.forename: Vojtĕch
authors.initials: V
authors.lastname: Mornstein
mesh_terms: D000970:Antineoplastic Agents / Q000032:analysis / Q000494:pharmacology; D002945:Cisplatin / Q000032:analysis* / Q000494:pharmacology*; D003131:Combined Modality Therapy / Q000379:methods*; D003470:Culture Media / Q000032:analysis; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000628:therapy; D011048:Polarography / Q000379:methods*; D013997:Time Factors; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014464:Ultrasonic Therapy
chemical_list: D000970:Antineoplastic Agents; D003470:Culture Media; D002945:Cisplatin